studies assessed mutagen sensitivity lung cancer lc risk associations context multiple epidemiological risk factors evaluated mutagen sensitivity susceptibility marker explored interplay genetic marker multiple epidemiologic risk factors modulating lc risk largest study included NUMBER newly diagnosed lc patients NUMBER controls matched age gender ethnicity smoking status cases exhibited significantly higher mutagen sensitivity controls bleomycin NUMBER vs NUMBER p NUMBER benzoapyrene diol epoxide bpde assays NUMBER vs NUMBER p NUMBER mutagen sensitivity exhibited relationship lc risk quartile analysis p trend NUMBER smokers history emphysema absence hay fever history lc relatives belomycin sensitivity high identified NUMBER significant risk factors stepwise logistic regression model odds ratios ors NUMBER NUMBER NUMBER NUMBER NUMBER respectively analyses joint effects risk factors showed compared reference group subjects exposure aforementioned risk factors ors exposure NUMBER NUMBER NUMBER NUMBER NUMBER risk factors NUMBER NUMBER NUMBER NUMBER NUMBER respectively p trend NUMBER study strongly supports mutagen sensitivity predisposition factor lc demonstrates importance assessing multiple risk factors comprehensively assess lc risk new integrative approach facilitate identification subgroups important implications lc prevention case control dose response degree pack year high risk breaks cell breaks cell